RecruitingNCT01206920

The DC Cohort Longitudinal HIV Status Neutral Study

Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort

Sponsor

George Washington University

Enrollment

19,000 participants

Start Date

Jan 1, 2011

Study Type

OBSERVATIONAL

Conditions

HIV AIDS

Summary

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Eligibility

Inclusion Criteria14

Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
Patient is a minor who is consented by a parent or legal guardian.
Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection
PrEP (e.g., TDF/FTC, Descovy, Apretude)
Combination ART indicative of nPEP in an HIV-uninfected person
Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course)
Test positive for ≥1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year)
bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters
HIV tests at 2 or more different encounters
Patient requesting PrEP at their clinical visit
Patient requesting nPEP at their clinical visit
People who identify as injecting drugs
Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis